Advertisement

Archives of Dermatological Research

, Volume 285, Issue 6, pp 341–346 | Cite as

Immunohistochemical analysis of sensory nerves and neuropeptides, and their contacts with mast cells in developing and mature psoriatic lesions

  • A. Naukkarinen
  • I. Harvima
  • K. Paukkonen
  • M. -L. Aalto
  • M. Horsmanheimo
Short Communications

Abstract

The distribution of the neuropeptides substance P (SP), vasoactive intestinal polypeptide (VIP) and calcitonin gene related peptide (CGRP) was studied immunohistochemically in psoriatic skin during the Koebner response (6 h, 2 days, 7 days, 14 days, 21 days), and in mature psoriatic plaques, of 37 psoriatic patients. The morphological association of sensory nerves, SP and VIP with papillary mast cells was also monitored. The nerves containing SP, VIP or CGRP were very scanty in control skin, and in non-lesional and Koebner-negative psoriatic skin. The first psoriatic lesions were seen 7 days after tape stripping the symptomless psoriatic skin. SP- and VIP-containing nerves were slightly increased in Koebner-positive specimens, but the increase was very prominent in dermal papillae of mature psoriatic plaques. In the plaques, nerve-mast cell contacts were significantly increased (p<0.001) compared with non-lesional psoriatic skin. Only SP-positive fibres were detected in the epidermis and in contact with papillary mast cells. VIP was mainly located around capillaries where SP was also found. No change was noted in CGRP-positive fibres between lesional and non-lesional specimens. The appearance of SP and VIP in the capillary walls is morphological evidence for their function as vasodilators in psoriatic lesion. A slight increase in SP- and VIP-positive fibres in Koebner-positive specimens suggests that these neuropeptides may participate in the inflammatory reaction at an early stage. Their prominence in mature psoriatic plaques in turn indicates a role for them in the maintenance of psoriatic lesions. Morphological contacts between mast cells and SP-containing nerves give further evidence to the view that SP is capable of amplifying the inflammatory reaction also through the axon-reflex mechanism.

Key words

Sensory nerves Neuropeptides Mast cells Psoriasis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Al'Abadie MSK, Senior HJ, Bleehen SS, Gawkrodger DJ (1992) Neurogenic changes in psoriasis. An immunohistochemical study. J Invest Dermatol 98: 535Google Scholar
  2. 2.
    Anand P, Springall DR, Blank MA, Sellu D, Polak JM, Bloom SR (1991) Neuropeptides in skin disease: increased VIP in eczema and psoriasis but not axillary hyperhidrosis. Br J Dermatol 124: 547–549Google Scholar
  3. 3.
    Ansel J, Perry P, Brown J, Damm D, Phan T, Hart C, Luger T, Hefeneider S (1990) Cytokine modulation of keratinocyte cytokines. J Invest Dermatol 94: 101S-107SGoogle Scholar
  4. 4.
    Bernstein JE, Parish LC, Rappaport M, Rosenbaum MM, Roenigk HH (1986) Effects of topically applied capsaicin on moderate and severe psoriasis vulgaris. J Am Acad Dermatol 15: 504–507Google Scholar
  5. 5.
    Bienenstock J, Tomioka M, Matsuda H, Stead RH, Quinonez G, Simon GT, Coughlin MD, Denburg JA (1987) The role of mast cells in inflammatory processes: evidence for nerve/mast cell interactions. Int Arch Allergy Appl Immunol 82: 238–243Google Scholar
  6. 6.
    Bos JD, Hulsebosch HJ, Krieg SR, Bakker PM, Cormane RH (1983) Immunocompetent cells in psoriasis. Arch Dermatol Res 275: 181–189Google Scholar
  7. 7.
    Boyd AS, Neldner KH (1990) The isomorphic response of Koebner. Int J Dermatol 29: 401–410Google Scholar
  8. 8.
    Caughey GH, Leidig F, Viro NF, Nadel JA (1988) Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase. J Pharmacol Exp Ther 244: 133–137Google Scholar
  9. 9.
    Church MK, Lowman MA, Robinson C, Holgate ST, Benyon RC (1989) Interaction of neuropeptides with human mast cells. Int Arch Allergy Appl Immunol 88: 70–78Google Scholar
  10. 10.
    Eedy DJ, Johnston CF, Shaw C, Buchanan KD (1991) Neuropeptides in psoriasis: an immunocytochemical and radio-immunoassay study. J Invest Dermatol 96: 434–438Google Scholar
  11. 11.
    Farber EM, Nall ML (1974) The natural history of psoriasis in 5,600 patients. Dermatologica 148: 1–18Google Scholar
  12. 12.
    Farber EM, Nickoloff BJ, Recht B, Fraki JE (1986) Stress, symmetry, and psoriasis: possible role of neuropeptides. J Am Acad Dermatol 14: 305–311Google Scholar
  13. 13.
    Farber EM, Lanigan SW, Boer J (1990) The role of cutaneous sensory nerves in the maintenance of psoriasis. Int J Dermatol 29: 418–420Google Scholar
  14. 14.
    Foreman JC (1987) Peptides and neurogenic inflammation. Br Med Bull 43: 386–400Google Scholar
  15. 15.
    Foster CA, Mandak B, Kromer E, Rot A (1991) The neuropeptide Substance P is chemotactiv for human T cells. Clin Res 39: 535AGoogle Scholar
  16. 16.
    Haegerstrand A, Jonzon B, Dalsgaard C-J, Nilsson J (1989) Vasoactive intestinal polypeptide stimulates cell proliferation and adenylate cyclase activity in cultured human keratinocytes. Proc Natl Acad Sci USA 86: 5993–5996Google Scholar
  17. 17.
    Hartschuh W, Weihe E, Reinecke M (1983) Peptidergic (neurotensin, VIP, Substance P) nerve fibres in the skin. Immunohistochemical evidence for an involvement of neuropeptides in nociception, pruritus and inflammation. Br J Dermatol 109 [Suppl 25]: 14–17Google Scholar
  18. 18.
    Hartung H-P, Toyka KV (1989) Substance P, the immune system and inflammation. Int Rev Immunol 4: 229–249Google Scholar
  19. 19.
    Harvima IT, Naukkarinen A, Harvima RJ, Fraki JE (1988) Immunoperoxidase and enzyme-histochemical demonstration of human skin tryptase in cutaneous mast cells in normal and mastocytoma skin. Arch Dermatol Res 280: 363–370Google Scholar
  20. 20.
    Harvima IT, Naukkarinen A, Harvima RJ, Aalto M-L, NeittaanmÄki H, Horsmanheimo M (1990) Quantitative enzyme-histochemical analysis of tryptase- and chymase-containing mast cells in psoriatic skin. Arch Dermatol Res 282: 428–433Google Scholar
  21. 21.
    Johansson O, Nordlind K (1985) Immunohistochemical screening of psoriasis. Arch Dermatol Res 277: 156Google Scholar
  22. 22.
    Johansson O, Olsson A, Enhamre A, Hammer H, Goldstein M (1987) Phenylethanolamine N-methyl-transferase-like immunoreactivity in psoriasis. An immunohistochemical study on catecholamine synthesizing enzymes and neuropeptides of the skin. Acta Derm Venereol (Stockh) 67: 1–7Google Scholar
  23. 23.
    Kikuchi M, Fukuyama K (1988) Hydrolysis of neuropeptides by soluble dipeptidyl peptidase IV (DPP IV) purified from rat epidermis. J Invest Dermatol 90: 575Google Scholar
  24. 24.
    Krueger GG (1981) Psoriasis: Current concepts of its etiology and pathogenesis. In: Dobson RI, Triers BH (eds) Year book of dermatology. Year Book Medical Publishers, Chicago, pp 13–70Google Scholar
  25. 25.
    Lembeck F, Holzer P (1979) Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Naunyn Schmiedebergs Arch Pharmacol 310: 175–183Google Scholar
  26. 26.
    Lowman MA, Rees PH, Benyon RC, Church MK (1988) Human mast cell heterogeneity: histamine release from mast cells dispersed from skin, lung, adenoids, tonsils, and colon in response to IgE-dependent and nonimmunologic stimuli. J Allergy Clin Immunol 81: 590–597Google Scholar
  27. 27.
    Male D, Champion B, Cooke A, Owen M (1991) Advanced immunology, 2nd edn. Gower Medical, London, p 16.14Google Scholar
  28. 28.
    Matis WL, Lavker RM, Murphy GF (1990) Substance P induces the expression of an endothelial-leukocyte adhesion molecule by microvascular endothelium. J Invest Dermatol 94: 492–495Google Scholar
  29. 29.
    Naukkarinen A, Nickoloff BJ, Farber EM (1989) Quantification of cutaneous sensory nerves and their Substance P content in psoriasis. J Invest Dermatol 92: 126–129Google Scholar
  30. 30.
    Naukkarinen A, Harvima IT, Aalto M-L, Harvima RJ, Horsmanheimo M (1991) Quantitative analysis of contact sites between mast cells and sensory nerves in cutaneous psoriasis and lichen planus based on a histochemical double staining technique. Arch Dermatol Res 283: 433–437Google Scholar
  31. 31.
    Payan DG, Brewster DR, Missirian-Bustian A, Goetzl EJ (1984) Substance P recognition by a subset of human T lymphocytes. J Clin Invest 74: 1532–1539Google Scholar
  32. 32.
    Pincelli C, Fantini F, Romualdi P, Lesa G, Giannetti A (1990) Increased vasoactive intestinal polypeptide levels in lesional skin of psoriasis. Clin Res 38: 650AGoogle Scholar
  33. 33.
    Pincelli C, Fantini F, Romualdi P, Sevignani C, Lesa G, Benassi L, Giannetti A (1992) Substance P is diminished and vasoactive intestinal peptide is augmented in psoriatic lesions and these peptides exert disparate effects on the proliferation of cultured human keratinocytes. J Invest Dermatol 98: 421–427Google Scholar
  34. 34.
    Rabier M, Wilkinson DI, Farber EM (1991) Neuropeptides modulate leukotriene B4 mitogenicity towards cultured keratinocytes. Clin Res 39: 536AGoogle Scholar
  35. 35.
    Siegel S, Castellan Jr NJ (1988) Nonparametric statistics for the behavioral sciences, 2nd edn. McGraw-Hill, New York, pp 206–216Google Scholar
  36. 36.
    Tam EK, Caughey GH (1990) Degradation of airway neuropeptides by human lung tryptase. Am J Respir Cell Mol Biol 3: 27–32Google Scholar
  37. 37.
    Wallengren J, Ekman R, Moller H (1986) Substance P and vasoactive intestinal peptide in bullous and inflammatory skin disease. Acta Derm Venereol (Stockh) 66: 23–28Google Scholar
  38. 38.
    Wallengren J, Ekman R, Sundler F (1987) Occurrence and distribution of neuropeptides in the human skin. Acta Derm Venereol (Stockh) 67: 185–192Google Scholar

Copyright information

© Springer-Verlag 1993

Authors and Affiliations

  • A. Naukkarinen
    • 1
  • I. Harvima
    • 2
  • K. Paukkonen
    • 2
  • M. -L. Aalto
    • 1
  • M. Horsmanheimo
    • 2
  1. 1.Department of Clinical PathologyKuopio University HospitalKuopioFinland
  2. 2.Department of DermatologyUniversity of KuopioKuopioFinland

Personalised recommendations